Abiopharma

🔍 Bonstein Sara (Executive)

Company: INSMED Inc (INSM)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 5,998 shares of Common Stock (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 79,503.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 5,645 shares of Common Stock (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 85,148.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Acquired 31,280 shares of Stock Option (right to buy) at $177.12 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 31,280.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
• F2: Each RSU was granted on January 2, 2026 for no consideration.
• F3: Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest in full on February 1, 2029.
• F4: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.
• REMARKS: Exhibit List - Exhibit 24 - Power of Attorney